C4 Therapeutics Inc (CCCC) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.02x
C4 Therapeutics Inc (CCCC) has a Cash Flow Reinvestment Rate of 0.02x as of June 2019, reinvesting $641.00K (capex $641.00K ) from operating cash flow of $36.91 Million. Explore CCCC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
$641.00K
Capex + Investments
Operating Cash Flow
$36.91 Million
USD
Capital Expenditures
$641.00K
USD
C4 Therapeutics Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for C4 Therapeutics Inc across 1 annual periods. Also explore CCCC asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for C4 Therapeutics Inc (2019–2019)
Year-by-year capital reinvestment analysis for C4 Therapeutics Inc. For live market cap and broader valuation context, see C4 Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.05x | $2.97 Million | $55.61 Million | $1.35 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow